Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGF1 | P05230 | 1/20 | 0.32 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4549509 | 1.00 | FGF1 (0.32) | FGF1SMPD1 | |
| SCHEMBL4549519 | 1.00 | FGF1 (0.32) | FGF1SMPD1 | |
| SCHEMBL6815629 | 1.00 | FGF1 (0.32) | FGF1SMPD1 | |
| SCHEMBL19227801 | 1.00 | FGF1 (0.32) | FGF1SMPD1 | |
| SCHEMBL4549513 | 1.00 | FGF1 (0.32) | FGF1SMPD1 | |
| SCHEMBL14975760 | 1.00 | FGF1 (0.32) | FGF1SMPD1 | |
| Bromide SCHEMBL28927555 | 0.98 | FGF1 (0.34) | FGF1SMPD1 | |
| SCHEMBL17040061 | 0.98 | SMPD1 (0.32) | SMPD1 | |
| SCHEMBL26887185 | 0.98 | SMPD1 (0.32) | SMPD1 | |
| SCHEMBL16381374 | 0.88 | FGF1 (0.44) | FGF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11147219-B2 | Methods and systems for growing plants using silicate-based substrates, cultivation of enhanced photosynthetic productivity and photosafening by utilization of exogenous glycopyranosides for endogenous glycopyranosyl-protein derivatives, and formulations, process and systems for the same | INNOVATION HAMMER, LLC (US) | 2021-10-19 | — | — | US | disclosed |
| EP-3783093-A2 | METHOD FOR GROWING PLANTS USING SILICATE MICROBEADS AND PHOTOSAFENING BY UTILIZATION OF EXOGENOUS GLYCOPYRANOSIDES | Innovation Hammer LLC (US) | 2021-02-24 | — | — | EP | disclosed |
| EP-2782990-B1 | METHOD FOR GROWING PLANTS USING SILICATE MICROBEADS AND PHOTOSAFENING BY UTILIZATION OF EXOGENOUS GLYCOPYRANOSIDES | INNOVATION HAMMER LLC (US) | 2020-10-07 | — | — | EP | disclosed |
| US-20200113143-A1 | Methods And Systems For Growing Plants Using Silicate-Based Substrates, Cultivation Of Enhanced Photosynthetic Productivity And Photosafening By Utilization Of Exogenous Glycopyranosides For Endogenous Glycopyranosyl-Protein Derivatives, And Formulations, Processes And Systems For The Same | INNOVATION HAMMER LLC (US) | 2020-04-16 | — | — | US | disclosed |
| US-20180325045-A1 | Methods And Systems For Growing Plants Using Silicate-Based Substrates, Cultivation Of Enhanced Photosynthetic Productivity And Photosafening By Utilization Of Exogenous Glycopyranosides For Endogenous Glycopyranosyl-Protein Derivatives, And Formulations, Processes And Systems For The Same | INNOVATION HAMMER LLC (US) | 2018-11-15 | — | — | US | disclosed |
| US-10010029-B2 | Methods and systems for growing plants using silicate-based substrates, cultivation of enhanced photosynthetic productivity and photosafening by utilization of exogenous glycopyranosides for endogenous glycopyranosyl-protein derivatives, and formulations, processes and systems for the same | INNOVATION HAMMER, LLC (US) | 2018-07-03 | — | — | US | disclosed |
| US-20170164562-A1 | Methods And Systems For Growing Plants Using Silicate-Based Substrates, Cultivation Of Enhanced Photosynthetic Productivity And Photosafening By Utilization Of Exogenous Glycopyranosides For Endogenous Glycopyranosyl-Protein Derivatives, And Formulations, Processes And Systems For The Same | INNOVATION HAMMER LLC (US) | 2017-06-15 | — | — | US | disclosed |
| US-20140331555-A1 | Methods And Systems For Growing Plants Using Silicate-Based Substrates, Cultivation Of Enhanced Photosynthetic Productivity And Photosafening By Utilization Of Exogenous Glycopyranosides For Endogenous Glycopyranosyl-Protein Derivatives, And Formulations, Processes And Systems For The Same | INNOVATION HAMMER, LLC | 2014-11-13 | — | — | US | disclosed |
| US-20100016250-A1 | TOLL-LIKE RECEPTOR 9 AGONISTS | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2010-01-21 | — | — | US | disclosed |
| EP-2017281-A1 | TOLL-LIKE RECEPTOR 9 AGONISTS | Kyowa Hakko Kirin Co., Ltd. (JP) | 2009-01-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100016250-A1 | TOLL-LIKE RECEPTOR 9 AGONISTS | TLR9, TLR1, TLR7 | FGF1 1167/4885SMPD1 3109/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.